Prospective phase IIb study of AADC gene therapy in patients with aromatic L-amino acid decarboxylase (AADC) deficiency
Phase of Trial: Phase II
Latest Information Update: 16 Nov 2016
At a glance
- Drugs AAV-hAADC (Primary)
- Indications Inborn error amino acid metabolic disorders
- Focus Therapeutic Use
- 16 Nov 2016 According to an Agilis Biotherapeutics media release, first patient has been treated in the study.
- 16 Nov 2016 Status changed from not yet recruiting to recruiting, according to an Agilis Biotherapeutics media release.
- 11 Oct 2016 According to a Agilis Biotherapeutics media release, status changed from planning to not yet recruiting.